Company Quick10K Filing
Heyu Biological Technology
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-12
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-28
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-01-26
10-Q 2017-09-30 Filed 2017-12-26
10-Q 2017-06-30 Filed 2017-12-26
10-Q 2017-03-31 Filed 2017-12-26
10-K 2016-12-31 Filed 2017-12-07
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-10
10-Q 2012-03-31 Filed 2012-05-18
10-K 2011-12-31 Filed 2012-05-08
10-Q 2011-09-30 Filed 2012-05-08
10-K 2010-12-31 Filed 2011-04-15
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-31
8-K 2019-07-01
8-K 2019-03-21
8-K 2018-10-29
8-K 2018-10-19
8-K 2018-10-18
8-K 2018-10-12
8-K 2018-10-11
8-K 2018-10-08
8-K 2018-10-04
8-K 2018-09-28
8-K 2018-09-14
8-K 2018-08-03
8-K 2018-07-05
8-K 2018-04-20
8-K 2018-02-22

Heyu Biological Technology Financials

HEYU Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3,4463,1301,2845435848581,6561,5271,7651,5841,9291,6071,32660860927736424359000003898156452
Accounts Receivable4003209061104545258727888794741,9161,0811,2021,8971,933
Inventory1010399398395388378394388378236339292015161918188311
PP&E1,8321,8231,8151,8091,7991,7901,9251,77386688767812119
Assets10,88010,72410,69510,53810,44610,5439,9819,5198,0508,0064,4804,1904,5335,3594,0943,9964,4624,872000000591414171,079
Accounts Payable72321511131021428110252264859217106512208757
Long-Term Debt1,0001,0001,0301,0281,0241,1701,1671,000000
Liabilities1,4971,4732,0021,9421,9412,1452,1001,7273082702812557391,2853947315741,3322054634015272964258241,699
Stockholders' Equity9,3839,2518,6928,5968,5068,3987,8817,7937,7427,7374,1993,9353,7944,0743,7003,2653,8883,539-527-237-284-407-580
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue5763822272744617024761,0183,9541,1451,5392,419340147022287
Cost of Revenue703060855552521082912772406063,1938181,3171,19028013154
Gross Profit5943522642331951691751661694252364647613282221,229609134
R&D52428858515765596455605559525954535436
SG&A8224714243293186742523432895484476394316426015513532239131-06
Tax00-44000010-21-400000000000
Net Income-213-132-97-90-108-517-88-31-5-3,538-264-141280-374-435623-349-198-9-13-126-48-125-185
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating473-352-211-176-365-371-123-267-411-180-309-269-818-164-31897-288-103-21-13-18-127-67-325116
Cash Investing-5272204921,173-25091,341547006118000000
Cash Financing230-2-4146-4-4-4-1,111-22-13-1339-15-15-10-151318127127381170